Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-12-09

Clinical Trial Update: Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients

View source ↗

Summary

An ongoing research trial investigating EML4-ALK gene expression in pleural effusion or tumor tissue from lung cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Lung Cancer Patients | Status: UNKNOWN